for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Jiangsu Lianhuan Pharmaceutical Co. Ltd

600513.SS

Latest Trade

7.25CNY

Change

--(--)

Today's Range

--

 - 

--

52 Week Range

5.52

 - 

9.87

As of on the Shanghai Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
7.25
Open
--
Volume
--
3M AVG Volume
47.06
Today's High
--
Today's Low
--
52 Week High
9.87
52 Week Low
5.52
Shares Out (MIL)
288.11
Market Cap (MIL)
2,088.76
Forward P/E
--
Dividend (Yield %)
1.08

Latest Developments

More

Jiangsu Lianhuan Pharmaceutical announces 2017 dividend payment date on May 17

Jiangsu Lianhuan Pharmaceutical Elects Chairman

Jiangsu Lianhuan Pharmaceutical to pay annual cash div as 0.75 yuan per 10 shares for FY 2017

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Jiangsu Lianhuan Pharmaceutical Co. Ltd

Jiangsu Lianhuan Pharmaceutical Co., Ltd. is a China-based company, principally engaged in the research and development, production and sales of chemical medicines. The Company's products are mainly applied as urinary system medicines, antihistamines and cardiovascular medicines. The Company's products include Epristeride Tablets, Ebastine Tablets, Felodipine Tablets, Felodipine Sustained Release Capsules, Simvastatin Tablets, Lumbrokinase Capsulesand and Balofloxacin Tablets. The Company distributes its products within domestic market and to overseas markets.

Industry

Major Drugs

Contact Info

No.21, Wenfeng Road

+86.514.87813082

http://www.lhpharma.com

Executive Leadership

Chunlai Xia

Chairman of the Board

Aixin Wang

Chief Financial Officer

Wenge Wu

General Manager, Director

Heping Pan

Deputy General Manager

Jun Zhou

Deputy General Manager

Key Stats

Price To Earnings (TTM)
27.15
Price To Sales (TTM)
1.88
Price To Book (MRQ)
2.18
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
25.84
LT Debt To Equity (MRQ)
0.00
Return on Investment (TTM)
8.21
Return on Equity (TTM)
5.81

Latest News

BRIEF-Jiangsu Lianhuan Pharmaceutical to set up medical tech JV with registered capital of 18 mln yuan

* Says it will set up a Nanjing-based medical tech JV with registered capital of 18 million yuan and hold 51 percent stake in the JV

BRIEF-Jiangsu Lianhuan Pharmaceutical to set up new energy unit in Yangzhou

* Says it plans to invest 20 million yuan to set up a wholly owned new energy unit in Yangzhou

BRIEF-Jiangsu Lianhuan Pharmaceutical to pay A shares annual div for FY 2016 on May 19

* Says it will pay cash dividend of 0.086 yuan(before tax)/share for 2016 and use additional paid-in capital to distribute 0.3 new shares/share to shareholders of record on May 18

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up